FDA-Inspected Site

Intas Pharmaceuticals Ltd.

4 FDA inspections are on record for Intas Pharmaceuticals Ltd. in Selaqui, India.

483· Form 483 issued

Selaqui, India · Last updated August 15, 2026

Overview

  • 4 FDA inspections are on record.
  • 3 inspections produced a Form 483.
  • The most recent recorded inspection date is 2025-09-16.

At a glance

Inspections

4

Form 483s

3

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
8 Sep 2025 – 16 Sep 2025Human DrugsWLOn file
15 Jan 2024 – 24 Jan 2024Human Drugs483On file
10 Jan 2023 – 20 Jan 2023Human DrugsWLView 483 →
8 Apr 2019 – 12 Apr 2019Human DrugsClean

Observations on record

Form 483 observations cited at this site, most recent first.

20 Jan 2023
21 CFR 211.110(a)

Control procedures to monitor and validate performance

Cited by Arsen Karapetyan, Teresa I Navas

20 Jan 2023
21 CFR 211.113(a)

Procedures for non-sterile drug products

Cited by Arsen Karapetyan, Teresa I Navas

20 Jan 2023
21 CFR 211.113(b)

Procedures for sterile drug products

Cited by Arsen Karapetyan, Teresa I Navas

20 Jan 2023
21 CFR 211.192

Written record of investigation incomplete

Cited by Arsen Karapetyan, Teresa I Navas

20 Jan 2023
21 CFR 211.22(d)

Procedures not in writing, fully followed

Cited by Arsen Karapetyan, Teresa I Navas

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.110(a)Cited across public-safe Form 483 observations1x
21 CFR 211.113(a)Cited across public-safe Form 483 observations1x
21 CFR 211.113(b)Cited across public-safe Form 483 observations1x
21 CFR 211.192Cited across public-safe Form 483 observations1x
21 CFR 211.22(d)Cited across public-safe Form 483 observations1x
21 CFR 211.63Cited across public-safe Form 483 observations1x
21 CFR 211.68(b)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Intas Pharmaceuticals Ltd.'s 3 Form 483s

Source PDFs and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat